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Background: Detection of B cell clonality is useful for assisting in the diagnosis of B cell lymphomas. Clonality
assessment can be accomplished through evaluation of KAPPA and LAMBDA light chain expression. Currently, only
slide based methods are available for the majority of patient biopsies and do not detect light chain protein or
mRNA in many B-cell lymphomas. Herein we evaluated a new method, known as colorimetric in situ hybridization
(CISH), with improved sensitivity and multiplexing capacity, for its usefulness in clonality detection in mature B cell
malignancies.
Methods: The KAPPA and LAMBDA ISH was performed on a Ventana Benchmark XT utilizing two color
chromogenetic detection. The probes comprised 2 haptenated riboprobes each approximately 500 base pairs long
directed against the conserved regions of either KAPPA or LAMBDA mRNA. The dual colors consisted of silver
deposition (black) for KAPPA light chain and a novel (pink) chromogen for LAMBDA light chain. Following
optimization, CISH allowed visualization of mRNA in benign B cells in reactive tissues including germinal center,
mantle zone, and post-germinal center cells. We then identified 79 cases of B cell lymphoma with formalin-fixed
paraffin-embedded (FFPE) biopsies including: follicular (36 cases), mantle cell (6 cases), marginal zone (12 cases),
lymphoplasmacytic (6 cases), small lymphocytic (4 cases), and diffuse large B cell (15 cases), which were selected on
the basis of either prior flow cytometry or immunohistochemistry (IHC) results to serve as the predicate, “gold
standard,” comparator.
Results: 39/79 (49.4%) cases were classified as KAPPA and 29/79 (36.7%) as LAMBDA light chain restricted; while 9/79
(11.3%) cases were classified as indeterminate. Of the 70 cases with KAPPA or LAMBDA light chain restricted CISH,
69/70 (98.6%) were concordant with the reference method, while 1/70 (1.4%) was discordant.
Conclusions: Optimized CISH detected lower levels of mRNA than can be visualized with current slide based
methods, making clonality assessment in FFPE biopsies possible for mature B cell neoplasms. In this preliminary
study, CISH was highly accurate compared to flow cytometry or IHC. CISH offers the possibility of wider applicability
of light chain ISH and is likely to become a useful diagnostic tool.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1430491067123856
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Detection of B cell clonality has long been a useful tool
for identification of monoclonal B cell populations, which
are potentially malignant, from polyclonal B cell popula-
tions that result during the normal immune response [1].
The copy number range of light chain mRNA and protein
expressed by B cells is variable and depends on stage of
differentiation. While naive and memory cells may have
only 10-100 mRNA copies per cell, plasma cells may have
approximately 100,000 mRNA copies per cell [1]. There-
fore detection methods need to have a wide dynamic
range to be suitable for application in different types of
B cell malignancies.
Detection of B cell monoclonality in diagnostic pathology
clinical laboratories can follow one of 4 basic methods. If
fresh tissue is available, then disassociation of the lymphoid
cells followed by immunofluoresence staining and flow
cytometric analysis is common. This technique gives a
level of sensitivity suitable for detecting the level of
kappa or lambda protein found on the surface of all
stages of B cell development [2]. If a permeabilization
step is used in cell preparation prior to staining, then
cytoplasmic light chain protein can be detected in
plasma cells and lymphoplasmacytic cells [3]. While a
highly successful method, the need for fresh unfixed
tissue excludes many cases from analysis. If lymphoma
is not suspected ahead of time or only a limited
amount of biopsy material is obtained, then often only
fixed tissues are available. In this common situation,
immunohistochemical (IHC) detection methods of kappa
and lambda light chain protein in formalin fixed, paraffin
embedded tissues (FFPET) are widely used. However,
these are somewhat limited by high background due to
the presence of normal physiologic interstitial Ig and the
low abundance of KAPPA and LAMBDA mRNA and pro-














Figure 1 Ig mRNA levels increase with B cell differentiation. As B lymp
naïve B cells to germinal center cells to post-germinal center cells then to
Current slide-based methods are generally able to detect the mRNA levels
germinal center stages).germinal center B cells [4]. Assessment of mRNA avoids
the issue of interstitial Ig signal since mRNA is short-lived
and intra-cytoplasmic. In situ hybridization (ISH) for mRNA
is therefore used in many laboratories. However, current
methods allow visualization of mRNA levels of B cells only
in the later stages of differentiation and so do not have the
dynamic range of flow cytometry (see Figure 1) [5,6] Finally,
molecular methods aimed at amplification of KAPPA and
LAMBDA light chain genes and examination for a predom-
inant rearrangement motif are also used. These techniques
usually performed in molecular laboratories, require longer
time as nucleic acid extraction and amplification are
needed and do not retain morphologic context i.e. exact
visualization of the cell of interest [7]. Therefore, despite a
variety of current methods, there are still many cases
where assessment of B cell monoclonality is technically
challenging, posing a limit to the diagnostic process.
In diagnostic pathology, ISH on histologic sections com-
monly starts with haptenated probes (labeled with either
DNP (2,4-dinitorphenol) or DIG (digoxigenin), followed
by an anti-hapten antibody, and an indirect biotin strepta-
vidin system with either alkaline phosphatase or silver
deposition for visualization [8;9]. Clinical examples com-
mon in diagnostic hematopathology include detection of
KAPPA and LAMBDA mRNA, as discussed above, as well
as Epstein Barr Virus Encoded RNAs (EBER). New probe
design approaches eliminating any repeat segments, as
well as the development of novel haptens and chromogens
have opened the possibility for more specific staining with
greater sensitivity and the detection of multiple probes per
slide [8,9].
Given the advantages of ISH (suitability for fixed tis-
sues, absence of background) as well as technological
developments in the field, the current study sought to
develop a new methodology known as dual color in situ





 slide methods detect in this range) 
hocytes pass through stages of maturation from precursor B cells to
plasma cells, the level of mRNA encoding immunoglobulin increases.
found in the later stages of differentiation (generally in the post-
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methods in a series of non-Hodgkin B cell lymphomas.
Herein, we describe for the first time this new method




Benign tissues included 2 tonsils removed for tonsillitis
and 1 with reactive paracortical hyperplasia. B cell non-
Hodgkin lymphomas (B-NHL) cases were assembled as
follows: Stanford University submitted 19 cases with
flow cytometry results, Cleveland Clinic submitted 18
cases with flow cytometry results, the University of Ari-
zona submitted 27 cases with flow cytometry results,
and the University College of London submitted 15
cases with IHC results. The case criteria included a diag-
nosis of mature B-cell non-Hodgkin lymphoma, remaining
tumor in the paraffin block, and documented monotypic
light chain pattern by flow or IHC. Each site performed
flow cytometry according to their own clinical laboratory
standards and so was not standardized across the case
series. Decalcified samples from bone marrow were not
included since the method is not yet optimized for that set-
ting. This project was conducted under a human subjects
research ethical approval from the University of Arizona
Institutional Review Board (protocol # 0500000226) ac-
cording to the Declaration of Helsinki.
Probe synthesis and formulation
Novel KAPPA and LAMBDA anti-sense probes, comple-
mentary to mRNA encoding each light chain constant
region, were chemically labeled with different haptens
using Mirus linker arms as directed by the manufacturer
(Mirus Bio LLC, Madison, WI). Twenty-five nanograms
of each probe was suspended in one mL of Ribohybe™
(cat. 760-104, Ventana Medical Systems) solution and
placed into a dispenser.
RNA in situ hybridization and tyramide-chromogen
detection
All steps were executed using a VENTANA Benchmark
XT automated staining instrument (Ventana Medical
Systems). Formalin-fixed, paraffin-embedded tissue sam-
ples mounted on Superfrost slides were de-paraffined
and antigen retrieved using CC1 reagent and protease 3
(cat. 760-2020, Ventana Medical Systems). Following re-
trieval, cocktailed hapten-labeled KAPPA and LAMBDA
experimental anti-sense strand probes were dispensed
onto a slide, denatured at 80°C for 8 min, and hybridized
at 65°C for 6 hrs. Following hybridization, slides were
washed 3 times using 0.1× SSC at 75°C for 8 min. to re-
move non-specifically hybridized probe. Brightfield detec-
tion of each bound probe required a two-tiered sequentialamplification strategy as follows. Endogenous tissue
peroxidase activity was inactivated using PO inhibitor
(cat. 760-4143, Ventana Medical Systems). The KAPPA
probe was detected using an anti-KAPPA probe hapten
monoclonal antibody conjugated to horseradish peroxid-
ase/HRP to catalyze hapten amplification using a tyramide-
hapten conjugate and TSA-H2O2 reagent (cat. 760-4141,
Ventana Medical Systems). The procedure was repeated
to detect the labeled LAMBDA probe using tyramide-
mediated amplification of the second hapten. Control stud-
ies demonstrated that three successive applications of PO
inhibitor were required prior to LAMBDA signal amplifica-
tion to inactivate the HRP-conjugates used to amplify the
KAPPA probe signal; omission of the inactivation step
resulted in co-localization of signals and non-specific
mRNA signals. Chromogenic detection of the LAMBDA
then KAPPA associated haptens was accomplished se-
quentially using a similar amplification strategy which
included in order three applications of PO inhibitor,
application of a cognate anti-hapten monoclonal anti-
body and application of a tyramide-sulforhodamine B
chromogen conjugate (for LAMBDA mRNA) before
using a similar strategy to deposit the silver chromo-
gen (for KAPPA mRNA) (See Figure 2). Tissue nuclei
were stained using Hematoxylin; slides were then dehy-
drated using gradient alcohols and coverslipped. Cognate
cocktailed sense strand probes were used as negative con-
trols to determine background resulting from non-specific
probe interactions.
Slide interpretation
The slides were interpreted by 3 pathologists (SM, TG,
LR) without knowledge of the flow cytometry or IHC re-
sults. Each pathologist initially read all slides independ-
ently without access to each other’s interpretations. Results
between pathologists were then compared, followed by dis-
crepancy resolution by joint microscopic review to achieve
consensus. After a consensus interpretation was achieved,
the CISH results were unblinded and compared to the flow
cytometry and IHC results.
Dual color CISH for kappa/lambda mRNA is a new
technology with results not before visualized. Positive
staining was therefore carefully defined as demonstrating
a partial to full ring of punctuate cytoplasmic staining.
The signals were small and delicate similar in size to
iron particles identified in erythroid precursors using an
Prussian Blue stain on bone marrow aspirate smears. In
cells at the late stage of B cell differentiation such as
plasma or plasmacytic cells, the staining was sometimes
heavy enough to obscure the entire cell. Nucleolar
staining was considered non-specific. Indeterminate
staining was assigned when there was a lack of or min-
imal staining on the malignant B cells (no rings or par-
















Figure 2 2-Color RNA Detection Methodology. A cocktail of antisense hapten-labeled riboprobes, targeting the constant region of either
KAPPA or LAMBDA mRNA, was hybridized to de-paraffinized protease treated tissue samples. Following stringency washes the haptens were
sequentially detected using a cognate anti-hapten monoclonal antibody conjugated to HRP which catalyzed deposition of a tyramide-hapten
conjugate. Following inactivation of the HRP conjugate, each amplified hapten was then sequentially detected using a second anti-hapten antibody-HRP
conjugate which catalyzed silver or pink chromogen deposition.
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when there was no or minimal staining on malignant B
cells (no rings or partial rings) and the plasma cells, which
are expected to be strongly stained, were present but
unstained.Figure 3 Staining Pattern in Reactive Lymphoid Tissues. A: Low powe
mantle zone, and scattered paracortical B cells as well as intra-germinal cen
center demonstrating polyclonal centrocytes, centroblasts, and a few plasm
plasma cells (600×). D: High power view of reactive paracortical hyperpla
restricted B-immunoblast (pink arrow), negatively staining presumed T-im
arrowhead) (1000×).Results and discussion
Reactive tissues demonstrated a polyclonal pattern of
staining including both kappa expressing (black labeled
cells) and lambda expressing (pink labeled cells) (Figure 3).
Within the germinal centers, centroblasts, centrocytes,r view of tonsil showing polyclonal staining within germinal center and
ter and paracortical plasma cells (40×). B: High power view of germinal
a cells (500×). C: High power view of medullary sinuses with polyclonal
sia showing KAPPA restricted B-immunoblast (black arrow), LAMBDA
munoblast (blue arrow), and negatively staining histiocyte (blue
Figure 4 Light chain restriction in B cell lymphomas. A-B: CLL/SLL (A) residual germinal center on left with sheets of monoclonal KAPPA light
chain restricted lymphoma cells on the right (100×); (B) higher power view of KAPPA light chain restricted cells (500×). C-E: DLBCL (C) diffuse
sheets of LAMBDA light chain restricted cells (100×); (D) same case showing intermediate magnification of LAMBDA light chain restricted
lymphoma cells (400×); (E) same case showing higher power view with centroblastic morphology and LAMBDA light chain restriction. Rather than
an inherent difference in the chromogens, but rather due to the larger cell size and lower nuclear to cytoplasmic ratios in DLBCL as compared to
SLL or FL, the cellular detail is easier to appreciate in E than in images B or H (600×). F-H: Follicular lymphoma (F) low power view showing
neoplastic germinal centers with KAPPA light chain restriction and cuff of polyclonal plasma cells (100×); (G) same case at intermediate power
showing KAPPA light chain restricted FL; (H) same case at higher power showing KAPPA light chain restriction of both small and large neoplastic
cells (600×).
Table 2 Concordance of evaluable cases by lymphoma
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staining of the mantle zone lymphocytes could also be vi-
sualized. As expected, the plasma cells in the medullary si-
nuses were also polyclonal. In a lymph node with reactive
paracortical hyperplasia, a mixture of KAPPA and LAMBDA
expressing immunoblasts were identified as were immuno-
blasts which were negative for both KAPPA and LAMBDA
as well as KAPPA and LAMBDA negative immunoblasts,
which were presumed to be T-cell immunoblasts.
After determining that the dual CISH assay was able
to detect KAPPA and LAMBDA mRNA in mature B
cells of increasing differentiation stages as encountered
in peripheral lymphoid tissues, we next collected cases







Total 79 70/79 (88.6%)
Indeterminate 9/79 (11.3%) –
Concordant with
flow or IHC
69/79 (87.3%) 69/70 (98.6%)
Discordant with
flow or IHC
1/79 (1.3%) 1/70 (1.4%)populations (germinal center-, mantle zone-, marginal
zone-derived lymphomas). Benign precursor B cells
found in bone marrow and lymphoblastic leukemia/
lymphomas were not included. There were 79 total cases
which met all inclusion criteria representing 34 cases of
follicular lymphoma (FL), 7 cases of mantle cell lymph-
oma (MCL), 11 cases of marginal zone lymphoma (MZL),
6 cases of lymphoplasmacytic lymphoma (LPL), 15 cases
of diffuse large B cell lymphoma (DLBCL), 4 cases of
chronic lymphocytic leukemia/small lymphocytic lymph-
oma (CLL/SLL), and 2 cases of small B-cell non-Hodgkin
lymphoma, not otherwise specified. Photomicrographs ofdiagnosis
Diagnosis Concordance Discordance
Follicular 27/28 (96.4%) 1/28 (3.6%)
Mantle Cell 7/7 (100%) 0/7 (0%)
Marginal Zone 10/10 (100%) 0/11 (0%)
Lymphoplasmacytic 6/6 (100%) 0/6 (0%)
Diffuse Large B-cell 13/13 (100%) 0/13 (0%)
SLL/CLL 4/4 (100%) 0/4 (0%)
Small cell B-NHL, NOS 2/2 (100%) 0/2 (0%)
Total 69/70 (98.6%) 1/70 (1.4%)
Table 3 Indeterminate vs evaluable by lymphoma
diagnosis
Diagnosis Cases Indeterminate Evaluable
Follicular 34 6/34 (17.6%) 28/34 (82.4%)
Mantle cell 7 0/7 (0%) 7/7 (100%)
Marginal Zone 11 1/11 (9%) 10/11 (91%)
Lymphoplasmacytic 6 0/6 (0%) 6/6 (100%)
Diffuse Large B Cell 15 2/15 (13.3%) 13/15 (86.7%)
CLL/SLL 4 0/4 (0%) 4/4 (100%)
Small B Cell NHL, NOS 2 0/2 (0%) 2/2 (100%)
Total 79 9/79 (11.3%) 70/79 (88.6%)
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Table 1, 70/79 cases (88.6%) were found to have either
KAPPA (39/79, 49.4%) or LAMBDA (29/79, 36.7%) light
chain restriction in the presence of appropriate residual
plasma cell staining. The remaining cases were classified
as indeterminate (9/79, 11.3%) using the criteria described
in Methods. Of these 9 indeterminate cases, 5 lacked
staining in B cells with positive plasma cell staining and 4
lacked staining in B cells without discernible plasma cells
in the section (to serve as tissue positive control). There-
fore 75/79 (95%) of cases were considered to have suffi-
cient mRNA integrity to be reliably interpreted. Of the 70
cases with interpretable CISH, 69/70 (98.6%) were con-
cordant with the reference method (either flow cytometry
or IHC), while 1/70 (1.4%) was discordant (shown by diag-
nostic category in Table 2). The latter case was a follicular
lymphoma that showed KAPPA restriction by CISH and
LAMBDA by IHC. Further examination of the discrepant
cases demonstrated that 6/34 FL (17.6%), 1/11 MZL (9%),
and 2/15 DLBCL (13.3%) were deemed indeterminate byFigure 5 Non-specific nucleolar staining with lambda probe. A-C: Germ
LAMBDA positive cells (400×); (B&C): arrows point out KAPPA expressing ce
pink nucleolar staining (600×). D-E: Follicular lymphoma. (D) low power vie
expressing neither light chain (40×); (E): high power view of same case dem
LAMBDA light chain expression with non-specific pink nucleolar staining (6CISH but were found to be evaluable by flow cytometry
or IHC. These cases are detailed in Table 3.
Interestingly, 2 cases which were negative for surface
Ig by flow cytometry were submitted to the study. Sur-
face Ig negativity is well recognized and considered a
sign of monoclonality in the workup of B-NHL, and has
been reported in a variety of B cell lymphomas including
follicular lymphoma [10-12]. In this study, 2 FL were
surface Ig negative by flow cytometry. Both of these
cases had “indeterminate” CISH results. Of these, 1 case
contained positively stained polyclonal plasma cells (a true
SIg negative case by all methods), while the other case did
not contain any discernable plasma cells to indicate that
staining was or was not successful. This latter case could
therefore be considered either a true negative (non-Ig
expressing lymphoma) or perhaps a case with poorly
preserved mRNA.
A non-specific nucleolar staining was seen with the
LAMBDA probe in 14 cases including all categories of
lymphoma (a representative case is shown in Figure 5).
Among the 14 cases, 6 showed KAPPA restriction, 5
LAMBDA, and 3 were classified as “indeterminate” by
CISH. Because of the preservation of tissue morphology,
this nucleolar staining was easily distinguished from the
specific cytoplasmic pattern of KAPPA or LAMBDA
mRNA staining.
When considering the diagnosis of lymphoma in pa-
tient biopsies, the monoclonality or polyclonality of the
B cell populations is a critical component of the decision
making process. While many methods can be used, the
most common (flow cytometry) requires fresh tissue, or
does not take into account morphologic context (PCR),
or is insufficiently sensitive for the majority of B cell
NHL (current IHC and ISH methods) [5,6]. In thisinal center in a reactive tonsil. (A) polyclonal mixture of KAPPA and
lls as evidenced by black ring of cytoplasmic staining with non-specific
w of FL case which was indeterminate for KAPPA and lambda due to
onstrating lack of cytoplasmic staining pattern for either KAPPA or
00×).
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dual-color CISH technology for the evaluation of clonal-
ity of mature B cell populations in tissue sections. We
demonstrate that with new, repeat-free probes and sensi-
tive detection systems taking advantage of tyramide-
induced deposition of chromogens, it is possible to detect
not only KAPPA and LAMBDA mRNA levels typical of
plasma cells and other post-germinal center B cells but
even the very low level mRNA found in presumed naïve B
cells in the mantle zones and germinal center B cells. This
level of detection is then applicable to the lymphomas de-
rived from most stages of B cell differentiation. The ability
to automate the staining and then evaluate the results
using light microscopy for slide evaluation holds the po-
tential to easily integrate the CISH technique into routine
diagnostic practice.
Conclusions
In this study we describe a preliminary accuracy of 98%
as compared to reference methods including flow cy-
tometry and immunohistochemistry. There was only 1
case called KAPPA by CISH and LAMBDA by IHC,
which is difficult to explain biologically. However, the
explanation could be as simple as a technical or tran-
scriptional error in the original report. Nevertheless, bio-
logical complexity does exist in the interpretation of the
lambda CISH results due to the presence of non-specific
nucleolar staining with the LAMBDA probe seen in sev-
eral cases. Initially, this staining seemed to suggest con-
flicting results, particularly in the cases which had clear
KAPPA mRNA cytoplasmic black colored staining while
having apparent “LAMBDA” pink staining in the nucle-
oli of the same cells. However, a review of the literature re-
vealed that this staining pattern may result from cross
hybridization with the Ig lambda-like polypeptide 5 (IGLL5)
gene on chromosome 22, which is located within the im-
munoglobulin lambda locus but does not require somatic
rearrangement for expression, meaning that it can be
expressed in non-Ig expressing, non-B, cells [13]. As re-
cently demonstrated by Tubbs et al. cross-hybridization
with the LAMBDA CISH probe occurs because while the
first exon of IGLL5 gene is unrelated to immunoglobulin
variable genes, the second and third exons use the same
loci as the Ig-lambda joining 1 and the Ig-lambda constant
1 gene segments [13,14]. Recognition of this non-specific
pattern allowed interpretation of cases with pink nucleolar
staining as well as black cytoplasmic staining as KAPPA
restricted. In contrast, those with pink nucleolar staining
without cytoplasmic staining were scored as “indetermin-
ate”. In at least 2 cases, “indeterminate” is the most accur-
ate interpretation since by flow cytometry these were both
considered surface Ig-negative cases.
Dual-color CISH allowed for detection of both KAPPA
and LAMBDA mRNA on a single slide under a lightmicroscope, making interpretation of B-cell clonality in
tissue sections reliable and highly optimized in the con-
text of tissue architecture and cellular compartments.
This application should be of particular interest to pa-
thologists engaged in the field of lymphoma diagnos-
tics. The availability of additional novel haptens and
chromogens, which can be paired with highly specific
probes, allows for the possibility of additional multi-color
combinations and innumerable future applications.
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